Abbott Laboratories (ABT) |
|
125.83 1.12 (0.9%)
|
01-21 17:34 |
|
Open: |
126.81 |
Pre. Close: |
124.71 |
|
High:
|
127 |
Low:
|
124.86 |
|
Volume:
|
10,124,997 |
Market Cap:
|
222,504M |
|
|
|
|
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
127.386 - 128.23 |
128.23 - 128.993 |
|
Low:
|
122.754 - 123.84 |
123.84 - 124.823 |
|
Close:
|
124.169 - 125.863 |
125.863 - 127.394 |
|
Technical analysis |
as of: 2022-01-21 4:24:30 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 158.53 One year: 166.56 |
| Support: |
Support1: 124.61 Support2: 103.68 |
| Resistance: |
Resistance1: 135.73 Resistance2: 142.60 |
| Pivot: |
132.47  |
| Moving Average: |
MA(5): 126.26 MA(20): 134.52
MA(100): 127.99 MA(250): 122.78  |
| MACD: |
MACD(12,26): -2.13 Signal(9): -0.56 |
| Stochastic oscillator: |
%K(14,3): 3.59 %D(3): 4.16 |
| RSI: |
RSI(14): 31.24 |
| 52-week: |
High: 142.60 Low: 105.36 Change(%): 10.1 |
| Average Vol(K): |
3-Month: 5572 10-Days: 6628 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ABT has closed above bottom band by 16.7%. Bollinger Bands are 91.2% wider than normal. The large width of the bands suggest high volatility as compared to Abbott Laboratories's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 20 Jan 2022
See Which Of The Latest 13F Filers Holds Abbott Laboratories - Nasdaq
Thu, 20 Jan 2022
Why Has Abbott Stock Dropped In January And Is A Rebound Likely? - Seeking Alpha
Wed, 19 Jan 2022
March 18th Options Now Available For Abbott Laboratories (ABT) - Nasdaq
Wed, 19 Jan 2022
Abbott Laboratories (ABT) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
Sun, 16 Jan 2022
Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022? - The Motley Fool
Fri, 14 Jan 2022
Abbott (ABT) Gets FDA Nod for New Cardiac Mapping System - Nasdaq
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
1,770 |
| Shares Float (M) |
1,750 |
|
% Held by Insiders
|
0.73 |
|
% Held by Institutions
|
75.38 |
|
Shares Short (K)
|
8,390 |
|
Shares Short P. Month (K)
|
8,710 |
Stock Financials |
|
EPS
|
4.030 |
|
EPS Est This Year
|
2.500 |
|
EPS Est Next Year
|
2.820 |
|
Book Value (p.s.)
|
19.470 |
|
Profit Margin
|
17.12 |
|
Operating Margin
|
20.91 |
|
Return on Assets (ttm)
|
7.7 |
|
Return on Equity (ttm)
|
21.9 |
|
Qtrly Rev. Growth
|
23.4 |
|
Gross Profit (p.s.)
|
11.079 |
|
Sales Per Share
|
23.904 |
|
EBITDA (p.s.)
|
6.989 |
|
Qtrly Earnings Growth
|
70.50 |
|
Operating Cash Flow (M)
|
11,260 |
|
Levered Free Cash Flow (M)
|
8,130 |
Stock Valuations |
|
PE Ratio
|
31.22 |
|
PEG Ratio
|
|
|
Price to Book value
|
6.46 |
|
Price to Sales
|
5.26 |
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
1.800 |
|
Forward Dividend
|
1.880 |
|
Dividend Yield
|
0.01 |
|
Dividend Pay Date
|
2022-02-14 |
|
Ex-Dividend Date
|
2022-01-12 |
|
7 Binary Options
|
|
Your Ad Here
|
|
